Table I.
Patient characteristics
| Characteristic | Overall, N = 850∗ | Delay, N = 733∗ | No delay, n = 117∗ | P value |
|---|---|---|---|---|
| Age | 56 (44–66) | 57 (45–67) | 52 (35–64) | .001 |
| Sex | .050 | |||
| Female | 636 (74.82%) | 557 (75.99%) | 79 (67.52%) | |
| Male | 214 (25.18%) | 176 (24.01%) | 38 (32.48%) | |
| Ethnicity† | > .900 | |||
| Not Hispanic or Latino | 727 (89.09%) | 622 (88.98%) | 105 (89.74%) | |
| Hispanic or Latino | 89 (10.91%) | 77 (11.02%) | 12 (10.26%) | |
| Race‡ | .120 | |||
| Asian | 42 (5.51%) | 32 (4.90%) | 10 (9.17%) | |
| Native Hawaiian or other Pacific Islander | 1 (0.13%) | 1 (0.15%) | 0 (0.00%) | |
| Black or African American | 119 (15.62%) | 103 (15.77%) | 16 (14.68%) | |
| White | 567 (74.41%) | 485 (74.27%) | 82 (75.23%) | |
| >1 race | 33 (4.33%) | 32 (4.90%) | 1 (0.92%) | |
| Primary disease site§ | < .001 | |||
| Thyroid | 458 (54.20%) | 378 (51.85%) | 80 (68.97%) | |
| Parathyroid | 314 (37.16%) | 291 (39.92%) | 23 (19.83%) | |
| Adrenal | 55 (6.51%) | 43 (5.90%) | 12 (10.34%) | |
| Pancreatic/GI neuroendocrine tumors | 11 (1.30%) | 11 (1.51%) | 0 (0.00%) | |
| Other | 7 (0.83%) | 6 (0.82%) | 1 (0.86%) |
GI, gastrointestinal.
∗
Median (IQR); n (%).
†
34 patients with unknown ethnicity were excluded from percentage calculations.
‡
88 patients with unknown race were excluded from percentage calculations.
§
5 patients with unknown primary disease site; these were excluded from percentage calculations.